Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Harvard Business School
Dow
McKesson
AstraZeneca

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,028,222

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,028,222
Title: Stable liquid paracetamol compositions, and method for preparing same
Abstract:Novel stable paracetamol compositions for use in therapeutic chemistry and specifically galenic pharmacy are disclosed. The compositions contain a solution of paracetamol in an aqueous solvent combined with a buffer having a pH of 4 to 8, and a free radical capturing agent. A water-insoluble inert gas is carefully bubbled through the aqueous solvent to remove oxygen from the medium. Said compositions may also be combined with a centrally or peripherally acting analgesic agent, and are provided as injectable compositions for relieving pain.
Inventor(s): Dietlin; Francois (Le Pecq, FR), Fredj; Daniele (Gif-sur-Yvette, FR)
Assignee: SCR Pharmatop (FR)
Application Number:09/051,246
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,028,222
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use;

Drugs Protected by US Patent 6,028,222

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,028,222

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France96 09858Aug 05, 1996
France96 09858Aug 5, 1996
PCT Information
PCT FiledAugust 05, 1997PCT Application Number:PCT/FR97/01452
PCT Publication Date:February 12, 1998PCT Publication Number: WO98/05314

International Family Members for US Patent 6,028,222

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 957   Start Trial
African Regional IP Organization (ARIPO) 9801223   Start Trial
Austria 241972   Start Trial
Australia 3945197   Start Trial
Australia 742576   Start Trial
Brazil 9702362   Start Trial
Canada 2233924   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Merck
Johnson and Johnson
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.